Institutional Ownership
Curanex Pharmaceuticals Inc
CUSIP 23126K106COMCURXQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
8
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 111.1K | $56.8K |
| 2 | Two Sigma Securities, LLC | 56.7K | $29.0K |
| 3 | Xtx Topco Ltd | 51.3K | $26.2K |
| 4 | Citadel Advisors LLC | 50.6K | $25.9K |
| 5 | Two Sigma Investments, LP | 20.3K | $10.4K |
| 6 | Citigroup Inc | 19.3K | $9.9K |
| 7 | Jump Financial, LLC | 10.6K | $5.4K |
| 8 | Ubs Group AG | 8.0K | $4.1K |